Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT
Abstract To develop predictive models of side effect occurrence in GEPNET treated with PRRT. Metastatic GEPNETs patients treated in our centre with PRRT (177Lu-Oxodotreotide) from 2019 to 2020 were considered. Haematological, liver and renal toxicities were collected and graded according to CTCAE v5...
Guardado en:
Autores principales: | F. Scalorbi, G. Argiroffi, M. Baccini, L. Gherardini, V. Fuoco, N. Prinzi, S. Pusceddu, E. M. Garanzini, G. Centonze, M. Kirienko, E. Seregni, M. Milione, M. Maccauro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3380ac4098f3446e97f6596eaacd19af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PRRT2 mutations in paroxysmal kinesigenic dyskinesia with infantile convulsions in a Taiwanese cohort.
por: Yi-Chung Lee, et al.
Publicado: (2012) -
Heterogeneous pattern of selective pressure for PRRT2 in human populations, but no association with autism spectrum disorders.
por: Guillaume Huguet, et al.
Publicado: (2014) -
DURATION OF IMMUNE RESPONSE INDUCED BY THE VACCINE BASED ON RECOMBINANT Ag85, TB10 AND FliC PROTEINS
por: V. V. Yeremeev, et al.
Publicado: (2018) -
STUDIES ON PROTECTIVE EFFECTS OF A VACCINE, BASED ON RECOMBINANT Ag85, TB10 AND FliC PROTEINS
por: V. V. Yeremeev, et al.
Publicado: (2017) -
Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?
por: Jingci Chen, et al.
Publicado: (2021)